Stock 000931 BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Beijing Centergate Technologies (holding) Co., Ltd.

Equities

000931

CNE000001030

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
4.46 CNY -1.33% Intraday chart for Beijing Centergate Technologies (holding) Co., Ltd. +3.00% -24.02%
04-26 Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-18 Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5,212 7,388 5,189 5,776 4,632 4,421
Enterprise Value (EV) 1 5,482 7,892 5,745 6,590 5,496 5,169
P/E ratio 55.9 x 77.6 x 204 x -50.7 x -108 x 90.6 x
Yield - - - - - -
Capitalization / Revenue 2.94 x 3.46 x 2.9 x 2.95 x 2.25 x 1.94 x
EV / Revenue 3.09 x 3.7 x 3.21 x 3.37 x 2.67 x 2.27 x
EV / EBITDA 27.1 x 31.3 x 26.7 x 72.5 x 27.9 x 21.5 x
EV / FCF -760 x -67.3 x 367 x 16.7 x 22.3 x 43.3 x
FCF Yield -0.13% -1.49% 0.27% 5.99% 4.48% 2.31%
Price to Book 3.09 x 4.42 x 3.05 x 3.64 x 3.13 x 2.88 x
Nbr of stocks (in thousands) 753,127 753,127 753,127 753,127 753,127 753,127
Reference price 2 6.920 9.810 6.890 7.670 6.150 5.870
Announcement Date 16/04/19 29/04/20 26/04/21 26/04/22 26/04/23 18/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,774 2,135 1,790 1,956 2,060 2,277
EBITDA 1 202.1 252.5 214.8 90.95 197.2 240.4
EBIT 1 85.31 178.3 129.5 6.411 106.2 132.7
Operating Margin 4.81% 8.35% 7.23% 0.33% 5.16% 5.83%
Earnings before Tax (EBT) 1 158.1 165.7 81.55 -74.32 -8.273 87.02
Net income 1 93.14 95.22 25.43 -113.9 -42.85 48.78
Net margin 5.25% 4.46% 1.42% -5.83% -2.08% 2.14%
EPS 2 0.1237 0.1264 0.0338 -0.1513 -0.0569 0.0648
Free Cash Flow 1 -7.212 -117.2 15.66 394.8 246.5 119.5
FCF margin -0.41% -5.49% 0.88% 20.18% 11.96% 5.25%
FCF Conversion (EBITDA) - - 7.29% 434.06% 124.98% 49.7%
FCF Conversion (Net income) - - 61.58% - - 244.97%
Dividend per Share - - - - - -
Announcement Date 16/04/19 29/04/20 26/04/21 26/04/22 26/04/23 18/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 271 503 556 813 864 749
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.339 x 1.994 x 2.586 x 8.942 x 4.381 x 3.113 x
Free Cash Flow 1 -7.21 -117 15.7 395 246 120
ROE (net income / shareholders' equity) 6.56% 6.73% 2.94% -5.37% -1.73% 3.83%
ROA (Net income/ Total Assets) 1.49% 3.14% 2.3% 0.11% 1.83% 2.24%
Assets 1 6,269 3,037 1,106 -101,721 -2,337 2,182
Book Value Per Share 2 2.240 2.220 2.260 2.110 1.970 2.040
Cash Flow per Share 2 0.5000 0.3400 0.2700 0.2300 0.1600 0.2500
Capex 1 132 144 138 68.5 64.3 67.3
Capex / Sales 7.43% 6.73% 7.73% 3.5% 3.12% 2.96%
Announcement Date 16/04/19 29/04/20 26/04/21 26/04/22 26/04/23 18/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. Stock Beijing Centergate Technologies (holding) Co., Ltd.
-24.02% 465M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000931 Stock
  4. Financials Beijing Centergate Technologies (holding) Co., Ltd.